These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17603185)

  • 1. A simple method to improve the odds in finding 'lead-like' compounds from chemical libraries.
    Horio K; Muta H; Goto J; Hirayama N
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):980-4. PubMed ID: 17603185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design strategies for building drug-like chemical libraries.
    Mitchell T; Showell GA
    Curr Opin Drug Discov Devel; 2001 May; 4(3):314-8. PubMed ID: 11560064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for effective virtual screening and scaffold-hopping in chemical compounds.
    Wale N; Karypis G; Watson IA
    Comput Syst Bioinformatics Conf; 2007; 6():403-14. PubMed ID: 17951843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.
    Monge A; Arrault A; Marot C; Morin-Allory L
    Mol Divers; 2006 Aug; 10(3):389-403. PubMed ID: 17031540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptors, physical properties, and drug-likeness.
    Brüstle M; Beck B; Schindler T; King W; Mitchell T; Clark T
    J Med Chem; 2002 Aug; 45(16):3345-55. PubMed ID: 12139446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the performance of fingerprint similarity searching.
    Vogt M; Bajorath J
    Methods Mol Biol; 2011; 672():159-73. PubMed ID: 20838968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of chemical libraries for their druggability.
    Sirois S; Hatzakis G; Wei D; Du Q; Chou KC
    Comput Biol Chem; 2005 Feb; 29(1):55-67. PubMed ID: 15680586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery.
    Fink T; Reymond JL
    J Chem Inf Model; 2007; 47(2):342-53. PubMed ID: 17260980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2D fingerprint methods for multiple-template similarity searching on compound activity classes of increasing structural diversity.
    Tovar A; Eckert H; Bajorath J
    ChemMedChem; 2007 Feb; 2(2):208-17. PubMed ID: 17143917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the diversity represented in commercially-available databases.
    Bradley MP
    Mol Divers; 2002; 5(4):175-83. PubMed ID: 12549670
    [No Abstract]   [Full Text] [Related]  

  • 16. In silico screening of drug databases for TSE inhibitors.
    Lorenzen S; Dunkel M; Preissner R
    Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification.
    Li Q; Bender A; Pei J; Lai L
    J Chem Inf Model; 2007; 47(5):1776-86. PubMed ID: 17718552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening with support vector machines and structure kernels.
    Mahé P; Vert JP
    Comb Chem High Throughput Screen; 2009 May; 12(4):409-23. PubMed ID: 19442068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
    Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
    Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.